Business Context and Reporting Period
Company: Globus Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 8, 2025
Reporting Period: Preliminary unaudited results for the three-month period and fiscal year ended December 31, 2024.
Key Financial Metrics
This filing serves as a notification of a press release containing preliminary financial data. The 8-K text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained in the referenced press release (Exhibit 99.1).
Material Changes
The filing reports the issuance of preliminary unaudited net sales results for Q4 and the full fiscal year 2024. No specific quantitative changes versus prior periods are detailed within the body of this 8-K document.
Guidance, Outlook, and Management Commentary
- Guidance: The company issued preliminary guidance for certain financial measures for the 2025 fiscal year.
- Source: Detailed commentary and specific guidance figures are located in the press release dated January 8, 2025, attached as Exhibit 99.1.
- Legal Status: Information in this Item 2.02 and the attached exhibits is deemed "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2024 net sales figures.
- Verify the specific 2025 fiscal year guidance metrics provided in the press release.
- Confirm the unaudited status of the reported preliminary results.
- Check for any forward-looking statements and associated risk factors in the press release.